- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Universal Medical buys vascular firms
Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire
Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire andBiometrix Connecticut, for cash and about $650,000 in preferredstock.
Biometrix is developing Telepulse, a next-generation vasculardiagnostic system that includes a telemedicine capability by allowingattending physicians to transmit data for interpretation by aradiologist or vascular surgeon. The product has been clearedby the Food and Drug Administration and should be introduced inthe second half of 1996.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
